These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Author: Mandelli F, Cafolla A, Annino L, Amadori S, Gentile A, Bianco P, Dianzani F.
    Journal: J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545.
    Abstract:
    Twenty-five patients with Hairy Cell Leukemia (HCL), eleven in post-splenectomy progressive disease, have been treated as out-patients with alpha 2 (r) Interferon (IFN) for twelve months. Eighteen patients completed the treatment: four achieved Complete Response (CR), twelve Partial Response (PR) and two Minor Response (MR). The response to IFN has been CR or PR in 89% of cases and MR in 11%. Even if the IFN effective dose and the length of treatment remain to be determined, IFN at relatively low dose seems to become the first treatment of choice in HCL patients. The remaining seven patients, still under treatment, already achieved PR at least.
    [Abstract] [Full Text] [Related] [New Search]